Metabolic Effects of a Growth Hormone-Releasing Factor in Patients with HIV
Falutz J, Allas S, Blot K, et al. New England Journal of Medicine 2007;357:2359-2370.
What it found
Visceral fat fell and lipid levels improved compared with placebo. Glucose measures did not differ significantly between groups.
Limitations
Only people with HIV and abdominal fat accumulation. More withdrawals for side effects on tesamorelin than on placebo.
Research and education only. Not medical advice. Many peptides on this site are not approved by the FDA for human use. Doses shown are the ones used in published studies and are not a recommendation. Talk to a licensed clinician before using any of them. Read the full disclaimer.